Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 268.50p 265.00p 272.00p 268.50p 267.50p 268.50p 30,941 11:00:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 20.3 4.0 8.1 33.3 115.97

Tristel Share Discussion Threads

Showing 3101 to 3125 of 3125 messages
Chat Pages: 125  124  123  122  121  120  119  118  117  116  115  114  Older
DateSubjectAuthorDiscuss
10/8/2018
08:53
Tristel Global@TristelGlobal Discover the latest on digital traceability from Tristel Global at the 2018 ASUM meeting in Auckland!
piedro
25/7/2018
13:38
Looks like we may see 250p here
its the oxman
20/7/2018
16:28
That's me stopped out earlier - lost all momentum and the D sells hasn't helped sentiment either
davr0s
20/7/2018
15:11
The Directors' resulting interest in the Company's issued share capital: Director Options Placing Holding % issued Remaining Exercised Shares Post-Placing share Options Sold capital held Francisco Soler - 1,750,000 6,673,834 15.27% - Paul Swinney 502,915 502,915 468,129 1.07% 1,153,764 Paul Barnes - 209,085 366,095 0.84% 87,500
zipstuck
20/7/2018
12:23
Hey Sportii,Soler 19.56%Barnes 1.37%Swinney 1.12%Orr 0.029%HL plc 7.11%Stanley stockbrokers 6.09%According to Morning Star
thetrophyman
20/7/2018
12:06
Tristel: ‘Core’ 2018 Revenue May Have Advanced 18% As The Chairman Looks To Sell His (Now) 15% Shareholding In An ‘Orderly Manner’ 20 July 2018 By Maynard Paton https://tinyurl.com/y976kves
piedro
20/7/2018
10:42
Name Title Compensation Age Officer since Christopher Samler Non-Executive Chairman of the Board 50.00kGBP -- 2011 Paul Swinney Chief Executive, Executive Director 169.00kGBP 53 -- Elizabeth Dixon Group Finance Director, Executive Director 102.00kGBP 41 2010 Paul Barnes Company Secretary, Non-Executive Director 20.00kGBP -- 2004 Bruce Green Non-Executive Director -- 66 2008 Tom Jenkins Non-Executive Director -- -- 2017 David Orr Non-Executive Director -- 56 2015 Francisco Soler Non-Executive Director -- -- 2012 Officers and Directors data as of Jul 17 2018
deltaham
20/7/2018
09:54
How can I find information about the numbers of shares held by the directors? I am keen to know if the bod is still holding a substantial amount, following the recent transactions by few of them. Information on tristel website is not updated. It was last updated in March 2018. Thanks for any help.
sportii
20/7/2018
09:43
With board changing I expect more share sales from leavers Now a long term hold for next phase - the fireworks are over.
zipstuck
18/7/2018
00:29
Presentation now on website https://www.tristel.com/sites/default/files/shareholder_open_day_presentation_2018_.pdf
piedro
17/7/2018
21:43
I had the impression that the Board members are at a stage in their lives where they want to diversify their wealth having worked hard to make the company successful. Additionally the share price is fairly full at the moment. US looks good but it not going to be instant lift off feeding through to the bottom line quickly, they remain some way from being able to make financial forecasts.
gopher
17/7/2018
16:17
A presentation will be made during the Open Day which will not contain any new material information. The presentation will be available on the Company website: www.tristel.com/investor-centre. - nothing published yet!!
piedro
17/7/2018
09:43
zipstuck, I believe the only "departing board member" named so far is Mr. Soler some approximate ages Francisco Soler .... 72 Paul Barnes ........ 64 Paul Swinney ....... 60 Elizabeth Dixon .... 48 Bruce Green ........ 73
piedro
17/7/2018
08:35
Am a little disappointed that departing board members did not show more conviction and hold for FDA result next year.
zipstuck
16/7/2018
18:05
"Satisfy market demand" phrase was used during a similar director placing in April last year. Price then was 175p. Hopefully these latest sales are not an omen of something sinister. Difficult to understand the orchestrated selling when US project has finally achieved a product approval milestone and potential comes closer... Perhaps Soler and Barnes need some money to pump into MobileODT. Only Swinney confirms in the later statement that he won't sell more shares "in the foreseeable future"
tmfmayn
16/7/2018
16:56
My thoughts exactly
best1467
16/7/2018
14:37
Looks like we know the reason for last weeks weakness then - clearly some in the know. I wish they wouldn't use the phrase "to satisfy institutional demand" - just so condescending. Just say you want to offload some shares and we'd respect you a lot more rather than trying to dress it up. Might be an interesting open day tomorrow now
davr0s
15/7/2018
17:07
13 July, 2018 - 11:05 By Tony Quested Tristel goes for the burn in US after record performance hTTps://www.businessweekly.co.uk/news/local-sharewatch/tristel-goes-burn-us-after-record-performance nothing new except ... for the photo
piedro
14/7/2018
10:05
Added a few k more at just over £2.90
eentweedrie
14/7/2018
10:02
H2 to H1 shows better sales growth momentum and is encouraging before the anticipated ramp up in sales in the US next year.
zipstuck
13/7/2018
12:01
"Now, it is time for me to announce my retirement. I shall step down as Chair and director at our AGM in December. The Board has taken its first steps to initiate the search for a new Chairman and we intend to refresh the Board as we look to follow the guidelines of the Quoted Company Alliance Corporate Governance Code for Small and Mid-Size Quoted Companies. I remain a long-term supporter of Tristel." A very important announcement - Interim Chairman retiring and refreshing of the Board. This indicates that they consider that Tristel is ready to become an 'international company' and that requires a board of directors with a different perspective. AIMHO What the "Quoted Company Alliance Corporate Governance Code for Small and Mid-Size Quoted Companies" is I don't know but costs £55 to download a copy.
piedro
13/7/2018
10:52
The value is in the next FDA approval
zipstuck
13/7/2018
09:45
May be an opportunity to top up as this seems the usual market response to what is a fairly decent update. Sad to see the Chairman go but I'm sure they will find a capable replacement and further approvals stateside plus, crucially, actual sales in the US should push the price onwards to 350.
zimbtrader
13/7/2018
09:36
I trade and screen out the story as its all noise/bias as far as I'm concerned. So to me we have sellers willing to sell price down and buyers not yet willing to bid it up. Suspect there were stops sitting sub 300 that got hit. I review EOD so will take stock then and see if 300 has held or not
davr0s
13/7/2018
09:33
Not familiar with the story here, is it just in line numbers on a high rating or chairman leaving?
its the oxman
Chat Pages: 125  124  123  122  121  120  119  118  117  116  115  114  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180814 13:35:25